lobbying_activities: 1332793
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1332793 | 5e7064db-a4c3-4f3c-9c55-0060b2f14058 | Q4 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | POZEN, INC. | 2012 | fourth_quarter | PHA | To provide incentives for new drug development. No specific bills pending. | HOUSE OF REPRESENTATIVES,SENATE | 36000 | 0 | 0 | 2013-01-11T11:32:05.333000-05:00 |